← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-10 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,486개
AntibodystalePeking Union Medical College Ho…Phase 3

trastuzumab (Herceptin, lapatinib/herceptin)

HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleCytoDyn, Inc.Preclinical

PRO 140 (leronlimab, leronlimab (PRO 140))

TNBC; TNBC - Triple-Negative Breast Cancer · TNBC

#TNBC#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
CGTBiologicstaleNational Cancer Institute (NCI)Phase 1

mCD19-CAR-CD28-CD3-zeta. (anti-CD19 CAR, mCD19-CAR-CD28-CD3-zeta., mCD19-CAR-CD28-CD3-zeta.(anti-CD19 CAR) retroviral vector-transduced allogeneic peripheral blood lymphocytes (PBL))

Hematologic Malignancies; Hematologic Neoplasms · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
AntibodystaleSpanish Cooperative Group for t…Phase 2

mFOLFOX-6 + cetuximab until disease progression or early withdrawal. (mFOLFOX-6 + cetuximab until disease progression or early withdrawal.)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleFudan UniversityPhase 3

mFOLFOX6 + Cetuximab (mFOLFOX6 + Cetuximab)

Colorectal Cancer; Liver Metastases · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleBlokhin's Russian Cancer Resear…Phase 2

mFOLFOX6 + dabrafenib and cetuximab or panitumumab in the first line of therapy (mFOLFOX6 + dabrafenib and cetuximab or panitumumab in the first line of therapy)

Neoplasms · Neoplasms

#Neoplasms#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleUniversity Hospital, EssenPhase 2

atezolizumab (Tecentriq, mFOLFOX6, Atezolizumab and Bevacizumab)

Biliary Tract Cancer · Biliary Tract Cancer

#BiliaryTractCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
CGTBiologicstaleUniversity of MiamiPhase 2

mTOR inhibitor + Selective estrogen receptor modulator (mTOR inhibitor + Selective estrogen receptor modulator)

Breast Cancer; ER-positive Breast Cancer · HER2

#HER2#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

modifiedFOLFOX6 + Cetuximab (modifiedFOLFOX6 + Cetuximab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
ADCBiologicstaleCSPC Megalith Biopharmaceutical…Phase 2

monotherapy chemotherapy (monotherapy chemotherapy)

Advanced Solid Tumors; Breast Cancer · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 44.4%임상시험 1상태 RECRUITING
AntibodystaleThe Greater Poland Cancer CentrePreclinical

doxorubicin, cyclophosphamide, paclitaxel, trastuzumab, pertuzumab (neoadjuvant treatment, neoadjuvant treatment (doxorubicin, cyclophosphamide, paclitaxel, trastuzumab, pertuzumab))

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, nivolumab combined with SOX)

Immune Suppression; Gastric Cancer · Immune Suppression

#ImmuneSuppression#Antibody#Phase2#항체#면역항체+3
효능 ORR 27.8%임상시험 1상태 RECRUITING
AntibodystaleSpanish Cooperative Group for t…Phase 2

durvalumab (Imfinzi, olaparib+durvalumab)

Metastatic Pancreatic Cancer · Metastatic Pancreatic Cancer

#MetastaticPancreaticCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
CGTBiologicstaleCG Oncology, Inc.Phase 2

oncolytic adenovirus expressing GMCSF (oncolytic adenovirus expressing GMCSF)

Bladder Cancer; High Grade · Bladder Cancer

#BladderCancer#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 5%임상시험 1상태 DISCONTINUED
AntibodystaleChinese PLA General HospitalPhase 2

oxaliplatin+capecitabine+bevacizumab+PD-1 antibody (oxaliplatin+capecitabine+bevacizumab+PD-1 antibody)

Colorectal Cancer; RAS Mutation · PD-1

#PD-1#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleDorte NielsenPhase 2

trastuzumab (Herceptin, oxaliplatin, capecitabine, trastuzumab)

Metastatic Breast Cancer; Liver Metastases · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleMt. Sinai Medical Center, MiamiPhase 2

oxaliplatin, gemcitabine, bevacizumab (oxaliplatin, gemcitabine, bevacizumab)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleWiSP Wissenschaftlicher Service…Phase 2

trastuzumab (Herceptin, paclitaxel plus trastuzumab)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleSpanish Lung Cancer GroupPreclinical

paclitaxel, carboplatin and bevacizumab (paclitaxel, carboplatin and bevacizumab)

Nonsquamous Nonsmall Cell Neoplasm of Lung · Nonsquamous Nonsmall Cell Neoplasm of Lu

#NonsquamousNonsmallCellNeoplasmo#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleGuangdong Provincial People's H…Phase 2

trastuzumab (Herceptin, palbociclib and exemestane plus trastuzumab and pyrotinib)

Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE

73 / 75 페이지

← 이전다음 →